DE60235852D1 - Kondensationsaerosol enthaltend Loxapine oder Prochlorperazine zur Inhalation - Google Patents
Kondensationsaerosol enthaltend Loxapine oder Prochlorperazine zur InhalationInfo
- Publication number
- DE60235852D1 DE60235852D1 DE60235852T DE60235852T DE60235852D1 DE 60235852 D1 DE60235852 D1 DE 60235852D1 DE 60235852 T DE60235852 T DE 60235852T DE 60235852 T DE60235852 T DE 60235852T DE 60235852 D1 DE60235852 D1 DE 60235852D1
- Authority
- DE
- Germany
- Prior art keywords
- inhalation
- antipsychotic
- composition
- mammal
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24V—COLLECTION, PRODUCTION OR USE OF HEAT NOT OTHERWISE PROVIDED FOR
- F24V30/00—Apparatus or devices using heat produced by exothermal chemical reactions other than combustion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
- A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
- A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29420301P | 2001-05-24 | 2001-05-24 | |
US31747901P | 2001-09-05 | 2001-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60235852D1 true DE60235852D1 (de) | 2010-05-12 |
Family
ID=30772632
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60235851T Expired - Lifetime DE60235851D1 (de) | 2001-05-24 | 2002-05-17 | Kondensationsaerosol enthaltend Zaleplon zur Inhalation |
DE60228232T Expired - Lifetime DE60228232D1 (de) | 2001-05-24 | 2002-05-20 | Verabreichung von antipsychotika durch inhalation |
DE60235852T Expired - Lifetime DE60235852D1 (de) | 2001-05-24 | 2002-05-20 | Kondensationsaerosol enthaltend Loxapine oder Prochlorperazine zur Inhalation |
DE60220909T Expired - Lifetime DE60220909T2 (de) | 2001-05-24 | 2002-05-22 | Verabreichung von arzneimitteln zur behandlung von erektionsstörungen durch inhalation |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60235851T Expired - Lifetime DE60235851D1 (de) | 2001-05-24 | 2002-05-17 | Kondensationsaerosol enthaltend Zaleplon zur Inhalation |
DE60228232T Expired - Lifetime DE60228232D1 (de) | 2001-05-24 | 2002-05-20 | Verabreichung von antipsychotika durch inhalation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60220909T Expired - Lifetime DE60220909T2 (de) | 2001-05-24 | 2002-05-22 | Verabreichung von arzneimitteln zur behandlung von erektionsstörungen durch inhalation |
Country Status (16)
Country | Link |
---|---|
US (75) | US6737042B2 (de) |
EP (14) | EP1392262A1 (de) |
JP (7) | JP2005503425A (de) |
AT (11) | ATE406878T1 (de) |
AU (3) | AU2002314784A1 (de) |
BE (1) | BE2013C054I2 (de) |
CA (7) | CA2446904A1 (de) |
DE (4) | DE60235851D1 (de) |
DK (1) | DK1389098T3 (de) |
ES (5) | ES2312571T3 (de) |
FR (1) | FR13C0051I1 (de) |
MX (2) | MXPA03010703A (de) |
NZ (6) | NZ529422A (de) |
PL (3) | PL363996A1 (de) |
PT (2) | PT1389098E (de) |
WO (1) | WO2002094236A1 (de) |
Families Citing this family (370)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030203036A1 (en) * | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
US7632517B2 (en) * | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
US7258850B2 (en) * | 1999-05-04 | 2007-08-21 | Aradigm Corporation | Methods and compositions for treating erectile dysfunction |
JP4932109B2 (ja) | 1999-07-12 | 2012-05-16 | キャプニア インコーポレイテッド | 頭痛、鼻炎及び他のありふれた病気を治す方法及び装置 |
US20070039615A1 (en) * | 1999-11-08 | 2007-02-22 | Capnia, Incorporated | Methods and apparatus for treating rhinitis |
US20060172017A1 (en) | 1999-11-08 | 2006-08-03 | Capnia, Incorporated | Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces |
WO2001036018A2 (en) * | 1999-11-08 | 2001-05-25 | Capnia Incorporated | Method and apparatus for relieving ailments using gases to increase the effectiveness of drugs |
WO2001078456A1 (fr) * | 2000-04-07 | 2001-10-18 | Ibiden Co., Ltd. | Element ceramique chauffant |
US20040115133A1 (en) * | 2000-05-10 | 2004-06-17 | Wermeling Daniel P. | Intranasal opioid compositions |
WO2002009669A2 (en) * | 2000-08-01 | 2002-02-07 | Inhale Therapeutic Systems, Inc. | Apparatus and process to produce particles having a narrow size distribution and particles made thereby |
US20020169507A1 (en) | 2000-12-14 | 2002-11-14 | David Malone | Interbody spine fusion cage |
SE0101204D0 (sv) * | 2001-04-04 | 2001-04-04 | Siemens Elema Ab | Heating device for respiration gas |
US6805853B2 (en) | 2001-11-09 | 2004-10-19 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
US7090830B2 (en) * | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US6759029B2 (en) | 2001-05-24 | 2004-07-06 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan and zolmitriptan through an inhalation route |
CA2447519C (en) * | 2001-05-24 | 2008-09-16 | Alexza Molecular Delivery Corporation | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US7458374B2 (en) * | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
EP1392262A1 (de) | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Verabreichung von arzneimittel-estern durch inhalation |
US20030131843A1 (en) * | 2001-11-21 | 2003-07-17 | Lu Amy T. | Open-celled substrates for drug delivery |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
EP1446102A1 (de) * | 2001-11-21 | 2004-08-18 | Alexza Molecular Delivery Corporation | Verabreichung von koffein durch inhalation |
US7523065B2 (en) * | 2001-12-12 | 2009-04-21 | Asset Trust, Inc. | Risk transfer supply chain system |
GB2384184B (en) * | 2002-01-10 | 2005-01-12 | Aea Technology Plc | Cannabis aerosol |
US7582284B2 (en) * | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
GB0216562D0 (en) * | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
WO2003094900A1 (en) * | 2002-05-13 | 2003-11-20 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
US20060193788A1 (en) * | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
CA2488613A1 (en) * | 2002-06-10 | 2003-12-18 | Wyeth | Novel formate salt of o-desmethyl-venlafaxine |
DE10234165B4 (de) * | 2002-07-26 | 2008-01-03 | Advanced Micro Devices, Inc., Sunnyvale | Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
US7644715B2 (en) * | 2002-10-31 | 2010-01-12 | Cooltouch, Incorporated | Restless leg syndrome treatment |
JP2006514934A (ja) * | 2002-11-26 | 2006-05-18 | アレックザ ファーマシューティカルズ, インコーポレイテッド | 疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用 |
US7550133B2 (en) | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
AU2003295823B2 (en) * | 2002-11-26 | 2009-11-05 | Alexza Pharmaceuticals, Inc. | Treatment of headache with antipsychotics delivered by inhalation |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
EP1596824A4 (de) * | 2003-02-04 | 2011-11-23 | Chrysalis Tech Inc | Aerosolformulierungen und aerosolabgabe von buspiron, buprenorphin, triazolam, zyckobenzaprin und zolpidem |
AU2004216550B2 (en) * | 2003-02-28 | 2010-06-03 | Ym Biosciences Inc. | Opioid delivery system |
US7648981B2 (en) * | 2003-02-28 | 2010-01-19 | Ym Biosciences Inc. | Opioid delivery system |
CN1938027A (zh) * | 2003-02-28 | 2007-03-28 | 德莱克斯疗法公司 | 阿片样物质递送系统 |
US7648982B2 (en) * | 2003-02-28 | 2010-01-19 | Ym Biosciences Inc. | Opioid delivery system |
WO2004089374A1 (en) * | 2003-04-14 | 2004-10-21 | Vectura Ltd | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
JP2007516404A (ja) * | 2003-05-21 | 2007-06-21 | アレックザ ファーマシューティカルズ, インコーポレイテッド | 光学点火されたかまたは電気点火された内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット |
GB0314149D0 (en) * | 2003-06-18 | 2003-07-23 | Generics Uk Ltd | Novel amorphous forms |
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
CN2718561Y (zh) * | 2003-07-11 | 2005-08-17 | 艾康生物技术(杭州)有限公司 | 用于取样签的保护套 |
US20050042177A1 (en) * | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
NZ527142A (en) * | 2003-07-23 | 2006-03-31 | Douglas Pharmaceuticals Ltd | A stable suspension formulation |
CA2534566A1 (en) * | 2003-08-04 | 2005-02-24 | Alexza Pharmaceuticals, Inc. | Substrates for drug delivery device and methods of preparing and use |
US20050037506A1 (en) * | 2003-08-04 | 2005-02-17 | Alexza Molecular Delivery Corporation | Methods of determining film thicknesses for an aerosol delivery article |
JP2007505136A (ja) * | 2003-09-10 | 2007-03-08 | マツプ・フアーマシユーテイカルズ・インコーポレーテツド | ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤 |
KR20060117909A (ko) * | 2003-09-15 | 2006-11-17 | 벡투라 리미티드 | 폐 흡입에 의한 조루 치료용 제약학적 조성물 |
GB2407498B (en) * | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
CN1305266C (zh) * | 2003-12-19 | 2007-03-14 | 深圳国人通信有限公司 | 基于嵌入式系统的无线局域网接入点设备 |
US20050171088A1 (en) * | 2004-01-30 | 2005-08-04 | Astrazeneca Ab | Treatment of psychoses with dibenzothiazepine antipsychotic |
US20050256553A1 (en) * | 2004-02-09 | 2005-11-17 | John Strisower | Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation |
WO2005086509A1 (en) * | 2004-03-04 | 2005-09-15 | Utstarcom Telecom Co., Ltd | The loads supporting mehod and system in radio base station |
US7422224B2 (en) * | 2004-04-13 | 2008-09-09 | Kimir Seatpost | Adjustable bicycle seat post assembly |
US7402777B2 (en) * | 2004-05-20 | 2008-07-22 | Alexza Pharmaceuticals, Inc. | Stable initiator compositions and igniters |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
US20100006092A1 (en) * | 2004-08-12 | 2010-01-14 | Alexza Pharmaceuticals, Inc. | Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages |
US20060039869A1 (en) * | 2004-08-17 | 2006-02-23 | Daniel Wermeling | Intranasal delivery of antipsychotic drugs |
EP1809240A4 (de) * | 2004-10-12 | 2010-06-16 | Alexza Pharmaceuticals Inc | Herzsichere schnelle arzneiverabreichung |
GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
JP5355893B2 (ja) * | 2004-12-16 | 2013-11-27 | シプラ・リミテッド | パントプラゾールナトリウムの製造方法 |
US7827983B2 (en) * | 2004-12-20 | 2010-11-09 | Hewlett-Packard Development Company, L.P. | Method for making a pharmaceutically active ingredient abuse-prevention device |
US20060130829A1 (en) * | 2004-12-20 | 2006-06-22 | Sexton Douglas A | Inhalation device |
AR053237A1 (es) | 2005-04-21 | 2007-04-25 | Medichem Sa | Proceso para la preparacion de quetiapina y fumarato de quetiapina |
US8062901B2 (en) * | 2005-04-30 | 2011-11-22 | Alere Switzerland Gmbh | Devices and methods for sample collection and analysis |
US20090117660A1 (en) * | 2005-04-30 | 2009-05-07 | Oakville Hong Kong Co., Limited | Devices and methods for sample collection and analysis |
RU2408368C2 (ru) | 2005-06-27 | 2011-01-10 | Биовэйл Лэборэториз Интернэшнл С.Р.Л. | Препараты соли бупропиона с модифицированным высвобождением |
JP2009502961A (ja) | 2005-07-29 | 2009-01-29 | コンサート ファーマシューティカルズ インコーポレイテッド | 新規な医薬組成物 |
EP1937217A2 (de) * | 2005-09-13 | 2008-07-02 | Elan Pharma International Limited | Nanoteilchenförmige tadalafil-formulierungen |
US20070092401A1 (en) * | 2005-10-26 | 2007-04-26 | Feier Liao | Devices and methods for sample collection and analysis |
WO2007064909A2 (en) * | 2005-12-01 | 2007-06-07 | Vapore, Inc. | Advanced capillary force vaporizers |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US9066847B2 (en) | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8202535B2 (en) * | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8252328B2 (en) | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8252329B2 (en) * | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
EP3546000A1 (de) | 2006-01-19 | 2019-10-02 | Optinose AS | Nasale verabreichung |
US20070183351A1 (en) * | 2006-02-03 | 2007-08-09 | Motorola, Inc. | Method and apparatus for providing service in a multi-ran communication network |
US20070256688A1 (en) * | 2006-04-21 | 2007-11-08 | Aradigm Corporation | Mechanical single dose intrapulmonary drug delivery devices |
US7909033B2 (en) | 2006-05-03 | 2011-03-22 | Comedica Incorporated | Breathing treatment apparatus |
US8536445B2 (en) * | 2006-06-02 | 2013-09-17 | Emcore Solar Power, Inc. | Inverted metamorphic multijunction solar cells |
US20070299687A1 (en) * | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
US8051854B2 (en) * | 2006-09-15 | 2011-11-08 | Comedica Incorporated | Continuous high-frequency oscillation breathing treatment apparatus |
GB0620661D0 (en) * | 2006-10-18 | 2006-11-29 | Pharmasol Ltd | Novel compounds |
US20090270438A1 (en) * | 2006-10-18 | 2009-10-29 | Clive Booles | Novel compositions and formulations |
US20080102097A1 (en) * | 2006-10-31 | 2008-05-01 | Zanella John M | Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent |
US8279765B2 (en) * | 2006-11-13 | 2012-10-02 | Motorola Solutions, Inc. | Method and apparatus for interworking in an inter-technology network |
US20080154374A1 (en) * | 2006-12-20 | 2008-06-26 | Robert David Labrom | Joint implant and a surgical method associated therewith |
US20080299048A1 (en) * | 2006-12-22 | 2008-12-04 | Alexza Pharmaceuticals, Inc. | Mixed drug aerosol compositions |
US20080275030A1 (en) | 2007-01-19 | 2008-11-06 | Sveinbjorn Gizurarson | Methods and Compositions for the Delivery of a Therapeutic Agent |
ES2538082T3 (es) * | 2007-02-11 | 2015-06-17 | Map Pharmaceuticals Inc | Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios |
WO2008112661A2 (en) | 2007-03-09 | 2008-09-18 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
WO2008115442A1 (en) | 2007-03-16 | 2008-09-25 | Concert Pharmceuticals, Inc. | Inhibitors of cholesterol ester transfer protein |
WO2008116165A2 (en) * | 2007-03-21 | 2008-09-25 | Next Safety, Inc. | Methods and systems of delivering medication via inhalation |
CA2701638A1 (en) * | 2007-04-02 | 2008-10-09 | Concert Pharmaceuticals Inc. | Pharmaceutical calcimimetics |
GB2448183A (en) * | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
WO2008124585A1 (en) * | 2007-04-06 | 2008-10-16 | Board Of Governors For Higher Education, State Of Rhode Island And Providence Planations | Lowering of proteins associated with alzheimer's disease by interrupting gene transcription with a small molecule |
WO2008128166A1 (en) * | 2007-04-13 | 2008-10-23 | Concert Pharmaceuticals Inc. | Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds |
KR20100012031A (ko) * | 2007-04-19 | 2010-02-04 | 콘서트 파마슈티컬즈, 인크. | 중수소화된 모르폴리닐 화합물 |
WO2008133949A1 (en) | 2007-04-25 | 2008-11-06 | Concert Pharmaceuticals, Inc. | Analogues of cilostazol |
EP2150525A1 (de) | 2007-05-01 | 2010-02-10 | Concert Pharmaceuticals Inc. | Naphthyl(ethyl)-acetamide |
PT2522668E (pt) | 2007-05-01 | 2015-06-09 | Concert Pharmaceuticals Inc | Compostos de morfinano |
EP4183787A1 (de) | 2007-05-01 | 2023-05-24 | Concert Pharmaceuticals Inc. | Morphinanverbindungen |
DK2152709T3 (da) | 2007-05-01 | 2012-06-04 | Concert Pharmaceuticals Inc | Morphinanforbindelser |
US7820666B2 (en) * | 2007-05-08 | 2010-10-26 | Concert Pharmaceuticals, Inc. | Tetrahydrotriazolopyrazine derivatives and uses thereof |
US9050434B2 (en) * | 2007-05-18 | 2015-06-09 | Comedica Incorporated | Lung therapy device |
US20090036357A1 (en) | 2007-06-12 | 2009-02-05 | Concert Pharmaceuticals, Inc. | Azapeptide derivatives |
CA2702317A1 (en) * | 2007-07-09 | 2009-01-15 | Concert Pharmaceuticals, Inc. | Novel pyrimidinecarboxamide derivatives |
US8442390B2 (en) * | 2007-08-29 | 2013-05-14 | Philip Morris Usa Inc. | Pulsed aerosol generation |
US8822498B2 (en) | 2007-09-13 | 2014-09-02 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof |
US8470360B2 (en) | 2008-04-18 | 2013-06-25 | Warsaw Orthopedic, Inc. | Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
US20090104964A1 (en) * | 2007-10-17 | 2009-04-23 | Igt | Gaming system, gaming device and gaming method providing player physical activation of the symbol generator |
US8410124B2 (en) * | 2007-10-18 | 2013-04-02 | Concert Pharmaceuticals Inc. | Deuterated etravirine |
GB0721394D0 (en) * | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
US20090162421A1 (en) * | 2007-12-21 | 2009-06-25 | Paz Arzneimittel-Entwicklungsgesellschaft Mbh | Drugs as well as their production and use in the treatment of pain-associated neuropathies |
US9138430B2 (en) * | 2007-12-27 | 2015-09-22 | Mylan Specialty L.P. | Formulation and method for the release of paroxetine in the large intestine |
CN101983058A (zh) * | 2008-02-05 | 2011-03-02 | 克莱拉有限公司 | 缓解抑郁症或改善认知的组合物和方法 |
US8757146B2 (en) | 2008-02-07 | 2014-06-24 | University Of Washington Through Its Center For Commercialization | Circumferential aerosol device |
BRPI0908107A2 (pt) | 2008-02-29 | 2019-09-24 | Concert Pharmaceuticals Inc | composto derivado de xantina substituída, composição farmacêutica que compreende esse composto, métodos de tratamento de uma enfermidade ou condição em um paciente com necessidade do mesmo, método de tratamento de enfermidade crônica dos rins, do fígado, relacionada com diabetes e de claudicação intermitente |
CN102014927A (zh) | 2008-03-06 | 2011-04-13 | 安纳考尔医药公司 | 作为抗炎药的含硼的小分子 |
US8201752B2 (en) * | 2008-03-10 | 2012-06-19 | Vapore, Inc. | Low energy vaporization of liquids: apparatus and methods |
US20090264489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation |
US8883768B2 (en) * | 2008-04-18 | 2014-11-11 | Warsaw Orthopedic, Inc. | Fluocinolone implants to protect against undesirable bone and cartilage destruction |
US8557273B2 (en) | 2008-04-18 | 2013-10-15 | Medtronic, Inc. | Medical devices and methods including polymers having biologically active agents therein |
US8722079B2 (en) | 2008-04-18 | 2014-05-13 | Warsaw Orthopedic, Inc. | Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine |
US8629172B2 (en) | 2008-04-18 | 2014-01-14 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising clonidine |
US8956641B2 (en) * | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
US20090264477A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc., An Indiana Corporation | Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
US9610243B2 (en) | 2008-04-18 | 2017-04-04 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US9132085B2 (en) * | 2008-04-18 | 2015-09-15 | Warsaw Orthopedic, Inc. | Compositions and methods for treating post-operative pain using clonidine and bupivacaine |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
US20090263451A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain |
US9072727B2 (en) | 2008-04-18 | 2015-07-07 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
US8946277B2 (en) * | 2008-04-18 | 2015-02-03 | Warsaw Orthopedic, Inc. | Clonidine formulations in a biodegradable polymer carrier |
US20090263489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation |
US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
US9132119B2 (en) * | 2008-04-18 | 2015-09-15 | Medtronic, Inc. | Clonidine formulation in a polyorthoester carrier |
US9282927B2 (en) | 2008-04-24 | 2016-03-15 | Invention Science Fund I, Llc | Methods and systems for modifying bioactive agent use |
US9662391B2 (en) | 2008-04-24 | 2017-05-30 | The Invention Science Fund I Llc | Side effect ameliorating combination therapeutic products and systems |
US9449150B2 (en) | 2008-04-24 | 2016-09-20 | The Invention Science Fund I, Llc | Combination treatment selection methods and systems |
US20100017001A1 (en) * | 2008-04-24 | 2010-01-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US9649469B2 (en) | 2008-04-24 | 2017-05-16 | The Invention Science Fund I Llc | Methods and systems for presenting a combination treatment |
US9560967B2 (en) | 2008-04-24 | 2017-02-07 | The Invention Science Fund I Llc | Systems and apparatus for measuring a bioactive agent effect |
EA022565B1 (ru) | 2008-05-27 | 2016-01-29 | Дзе Юниверсити Оф Мельбурн | Способы лечения млекопитающих с дисфункциями евстахиевой трубы |
WO2009146310A1 (en) * | 2008-05-28 | 2009-12-03 | Concert Pharmaceuticals Inc. | Deuterated tizanidine |
US7845277B2 (en) * | 2008-05-28 | 2010-12-07 | Autoliv Asp, Inc. | Header assembly |
US20100221221A1 (en) * | 2008-08-12 | 2010-09-02 | Concert Pharmaceuticals Inc. | N-phenyl-2-pyrimidineamine derivatives |
EP2334686B1 (de) | 2008-08-28 | 2019-02-27 | President and Fellows of Harvard College | Cortistatin-analoga und ihre synthese |
US20100065052A1 (en) * | 2008-09-16 | 2010-03-18 | Alexza Pharmaceuticals, Inc. | Heating Units |
US7834295B2 (en) | 2008-09-16 | 2010-11-16 | Alexza Pharmaceuticals, Inc. | Printable igniters |
PL3248978T3 (pl) | 2008-09-19 | 2019-12-31 | Concert Pharmaceuticals Inc. | Zdeuterowane związki morfinanu |
US20100098746A1 (en) * | 2008-10-20 | 2010-04-22 | Warsaw Orthopedic, Inc. | Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
EP2365808B1 (de) | 2008-10-30 | 2018-01-10 | Concert Pharmaceuticals Inc. | Kombination von morphinan-verbindungen und antidepressiva zur behandlung von pseudobulbärem affekt, neurologischen erkrankungen, hartnäckigen und chronischen schmerzen und gehirnverletzungen |
EP2397159A3 (de) | 2008-10-30 | 2012-02-22 | Concert Pharmaceuticals, Inc. | Kombination von Morphinan-Verbindungen und Antidepressiva zur Behandlung von hartnäckigen und chronischen Schmerzen |
US8198268B2 (en) * | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
RU2011122647A (ru) | 2008-11-04 | 2012-12-20 | Энкер Терапьютикс, Инк. | Cxcr4-рецепторные соединения |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
US8822546B2 (en) * | 2008-12-01 | 2014-09-02 | Medtronic, Inc. | Flowable pharmaceutical depot |
EP2370136A4 (de) * | 2008-12-01 | 2015-12-30 | Map Pharmaceuticals Inc | Inhalative freisetzungsverfahren und vorrichtungen |
WO2010065755A1 (en) | 2008-12-04 | 2010-06-10 | Concert Pharmaceuticals, Inc. | Deuterated pyridinones |
WO2010074753A1 (en) | 2008-12-23 | 2010-07-01 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
US20100163027A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100163036A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100168602A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc | Methods and systems for presenting an inhalation experience |
US8725529B2 (en) | 2008-12-30 | 2014-05-13 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US20100169259A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100163034A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100163024A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation | Methods and systems for presenting an inhalation experience |
US20100168525A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US8706518B2 (en) * | 2008-12-30 | 2014-04-22 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US8694330B2 (en) * | 2008-12-30 | 2014-04-08 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US8738395B2 (en) * | 2008-12-30 | 2014-05-27 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US20100163033A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US8712794B2 (en) * | 2008-12-30 | 2014-04-29 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US20100168529A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100166613A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100169260A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc | Methods and systems for presenting an inhalation experience |
US20100163038A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100163025A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc | Methods and systems for presenting an inhalation experience |
US20110053961A1 (en) | 2009-02-27 | 2011-03-03 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
US20100228097A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Methods and compositions to diagnose pain |
EP2229980B1 (de) * | 2009-03-16 | 2015-08-12 | Nuvolase, Inc. | Behandlung mikrobiologischer Krankheitserreger in einem Zehennagel mit antimikrobiellem Licht |
BRPI1009199A2 (pt) | 2009-03-17 | 2016-03-08 | Concert Pharmaceuticals Inc | compostos de pirazinoisoquinolina |
WO2010107964A1 (en) * | 2009-03-18 | 2010-09-23 | Pleiades Cardio-Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
US8548623B2 (en) | 2009-03-18 | 2013-10-01 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US20100239632A1 (en) * | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
WO2010138889A1 (en) | 2009-05-28 | 2010-12-02 | Concert Pharmaceuticals, Inc. | Peptides for the treatment of hcv infections |
US20100300433A1 (en) * | 2009-05-28 | 2010-12-02 | Alexza Pharmaceuticals, Inc. | Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol |
DK2443089T3 (da) | 2009-06-18 | 2014-06-16 | Concert Pharmaceuticals Inc | Deutereret isoindolin-1,3-dion-derivater som pde4- og tnf-alfa-inhibitorer |
JP2012531419A (ja) | 2009-06-23 | 2012-12-10 | コンサート ファーマシューティカルズ インコーポレイテッド | Gaba−a受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体 |
WO2010151804A1 (en) * | 2009-06-26 | 2010-12-29 | Map Pharmaceuticals, Inc. | Administration of dihydroergotamine mesylate particles using a metered dose inhaler |
US8617583B2 (en) * | 2009-07-17 | 2013-12-31 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis |
US20110015154A1 (en) * | 2009-07-20 | 2011-01-20 | Kellermann Gottfried H | Supporting acetylcholine function |
US8814922B2 (en) * | 2009-07-22 | 2014-08-26 | New Star Lasers, Inc. | Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure |
US8231891B2 (en) * | 2009-07-31 | 2012-07-31 | Warsaw Orthopedic, Inc. | Implantable drug depot for weight control |
US10758582B2 (en) * | 2009-08-17 | 2020-09-01 | Xten Capital Group, Inc. | Vaporized medicants and methods of use |
EP2765420B1 (de) * | 2009-09-09 | 2017-11-15 | Sensa Bues AB | Nachweis von Drogen in ausgeatmeter Luft |
CN102596264B (zh) | 2009-10-13 | 2016-09-07 | 菲利普莫里斯生产公司 | 空气清新设备 |
WO2011047315A1 (en) | 2009-10-15 | 2011-04-21 | Concert Pharmaceuticals, Inc. | Subsitituted benzimidazoles |
US20110097375A1 (en) | 2009-10-26 | 2011-04-28 | Warsaw Orthopedic, Inc. | Formulation for preventing or reducing bleeding at a surgical site |
US20110098265A1 (en) * | 2009-10-28 | 2011-04-28 | Neuroscience, Inc. | Methods for reducing cravings and impulses associated with addictive and compulsive behaviors |
US9151425B2 (en) * | 2009-11-02 | 2015-10-06 | Comedica Incorporated | Multiple conduit connector apparatus and method |
US20110100360A1 (en) * | 2009-11-02 | 2011-05-05 | Joseph Dee Faram | Composite lung therapy device and method |
WO2011094450A1 (en) | 2010-01-27 | 2011-08-04 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules |
EP2536696A1 (de) | 2010-02-18 | 2012-12-26 | Concert Pharmaceuticals Inc. | Pyrimidinderivate |
US9155795B2 (en) | 2010-02-26 | 2015-10-13 | Anchor Therapeutics, Inc. | CXCR4 receptor compounds |
US8575361B2 (en) | 2010-03-02 | 2013-11-05 | Concert Pharmaceuticals Inc. | Tetrahydronaphthalene derivatives |
EP2542534A1 (de) | 2010-03-02 | 2013-01-09 | Concert Pharmaceuticals Inc. | Deuterierte tetrahydronaphthalenderivate |
US9107922B2 (en) | 2010-07-16 | 2015-08-18 | Concert Pharmaceuticals, Inc. | Pyrimidinecarboxamide derivatives |
US20130142868A1 (en) * | 2010-08-20 | 2013-06-06 | University Of Washington | Circumferential Aerosol Device for Delivering Drugs to Olfactory Epithelium and Brain |
US20120048963A1 (en) | 2010-08-26 | 2012-03-01 | Alexza Pharmaceuticals, Inc. | Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter |
ES2898695T3 (es) | 2010-09-07 | 2022-03-08 | Anacor Pharmaceuticals Inc | Derivados de benzoxaborol para el tratamiento de infecciones bacterianas |
DE102010041840A1 (de) * | 2010-10-01 | 2012-04-05 | Bayerische Motoren Werke Aktiengesellschaft | Verfahren zur Herstellung einer Ventilationsbohrung in einem Lagerstuhl eines Kurbelgehäuses einer Hubkolben-Brennkraftmaschine |
WO2012079075A1 (en) | 2010-12-10 | 2012-06-14 | Concert Pharmaceuticals, Inc. | Deuterated phthalimide derivatives |
EP3834869A1 (de) | 2010-12-22 | 2021-06-16 | Syqe Medical Ltd. | System zur wirkstofffreisetzung |
US8447329B2 (en) | 2011-02-08 | 2013-05-21 | Longsand Limited | Method for spatially-accurate location of a device using audio-visual information |
RU2612506C2 (ru) | 2011-03-03 | 2017-03-09 | Импел Ньюрофарма Инк. | Устройство для назальной доставки лекарственных средств |
WO2012129381A1 (en) | 2011-03-22 | 2012-09-27 | Concert Pharmaceuticals Inc. | Deuterated preladenant |
US20140213553A1 (en) | 2011-05-03 | 2014-07-31 | Concert Pharmaceuticals Inc. | Carbamoylpyridone derivatives |
JP6645735B2 (ja) | 2011-05-09 | 2020-02-14 | インペル ニューロファーマ インコーポレイテッド | 鼻薬送達用ノズル |
US20140072621A1 (en) | 2011-05-09 | 2014-03-13 | The Cleveland Clinic Foundation | Composition and method to improve intestinal health |
WO2012154728A1 (en) | 2011-05-10 | 2012-11-15 | Concert Pharmaceuticals Inc. | Deuterated n-butyl bumetanide |
HUE032771T2 (en) | 2011-05-18 | 2017-10-30 | Concert Pharmaceuticals Inc | Deuterated ivacaftor derivatives |
CN104254540A (zh) | 2012-01-09 | 2014-12-31 | 安科治疗公司 | Apj受体化合物 |
WO2013130849A1 (en) | 2012-02-29 | 2013-09-06 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
JP5935877B2 (ja) * | 2012-03-30 | 2016-06-15 | 日本電気株式会社 | 動線データ解析装置、システム、プログラム及び方法 |
EP2836492B1 (de) | 2012-04-13 | 2018-03-14 | Concert Pharmaceuticals Inc. | Substituierte xanthinderivate |
WO2013159026A1 (en) | 2012-04-20 | 2013-10-24 | Concert Pharmaceuticals, Inc. | Deuterated rigosertib |
EP3882249A1 (de) | 2012-06-15 | 2021-09-22 | CoNCERT Pharmaceuticals, Inc. | Deuterierte derivate von ruxolitinib |
CA2908929C (en) | 2012-07-12 | 2021-01-26 | Concert Pharmaceuticals, Inc. | Deuterated idebenone |
EP2885303B1 (de) | 2012-08-17 | 2018-12-26 | CoNCERT Pharmaceuticals, Inc. | Deuteriertes baricitinib |
EP2711006A1 (de) | 2012-09-21 | 2014-03-26 | Basil Rigas | Produkt mit nikotinhaltigem Material und einem Antikrebsmittel |
WO2014078842A1 (en) | 2012-11-19 | 2014-05-22 | Concert Pharmaceuticals, Inc. | Deuterated cftr potentiators |
US10034988B2 (en) | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
US9795752B2 (en) | 2012-12-03 | 2017-10-24 | Mhs Care-Innovation, Llc | Combination respiratory therapy device, system, and method |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757529B2 (en) * | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
JP2016503798A (ja) | 2012-12-20 | 2016-02-08 | コンサート ファーマシューティカルズ インコーポレイテッド | 重水素化alk阻害剤 |
WO2014110322A2 (en) | 2013-01-11 | 2014-07-17 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
US9186860B2 (en) | 2013-01-28 | 2015-11-17 | Carl D. Luenser | Vaporizer kit for tobacco, medications, and the like |
AU2014237569B2 (en) | 2013-03-15 | 2019-03-14 | Concert Pharmaceuticals Inc. | Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase |
EA201892726A1 (ru) | 2013-03-15 | 2019-04-30 | Консерт Фармасьютикалс, Инк. | Дейтерированный палбоциклиб |
US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
HU231191B1 (hu) | 2013-04-15 | 2021-08-30 | Szegedi Tudományegyetem | Izotóp tartalmú morfin molekulák |
US10537692B2 (en) | 2013-04-28 | 2020-01-21 | Impel Neuropharma, Inc. | Medical unit dose container |
EP3607941A1 (de) | 2013-04-30 | 2020-02-12 | Otitopic Inc. | Trockenpulverformulierungen und verfahren zur verwendung |
CN104274427A (zh) * | 2013-07-03 | 2015-01-14 | 陆克塞纳医药公司 | 格拉司琼气溶胶组合物及其用途 |
CN104274426A (zh) | 2013-07-03 | 2015-01-14 | 陆克塞纳医药公司 | 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途 |
JP6397493B2 (ja) | 2013-07-11 | 2018-09-26 | アレックザ ファーマシューティカルズ, インコーポレイテッド | メタ−サリチル酸とのニコチン塩 |
US20160159861A1 (en) | 2013-07-18 | 2016-06-09 | Anchor Therapeutics, Inc. | APJ Receptor Compounds |
WO2015009889A1 (en) | 2013-07-18 | 2015-01-22 | Concert Pharmaceuticals, Inc. | Deuterated intedanib derivatives and their use for the treatment of proliferative disorders |
MX348595B (es) | 2013-08-02 | 2017-06-21 | Laboratorio Raam De Sahuayo S A De C V | Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion. |
US9676790B2 (en) | 2013-08-30 | 2017-06-13 | Concert Pharmaceuticals, Inc. | Substituted thienotriazolodiazapines |
US10194693B2 (en) | 2013-09-20 | 2019-02-05 | Fontem Holdings 1 B.V. | Aerosol generating device |
US9364815B2 (en) | 2013-11-07 | 2016-06-14 | Saudi Basic Industries Corporation | Method of preparing an alumina catalyst support and catalyst for dehydrogenation reactions, and its use |
WO2015095644A1 (en) | 2013-12-20 | 2015-06-25 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
EA032777B1 (ru) | 2013-12-24 | 2019-07-31 | Вирджиния Коммонвелт Юниверсити | Способ предотвращения или лечения почечной недостаточности |
TN2016000240A1 (en) | 2013-12-24 | 2017-10-06 | Harvard College | Cortistatin analogues and syntheses and uses thereof. |
US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
CN106102748A (zh) | 2014-02-20 | 2016-11-09 | 奥迪托皮克股份有限公司 | 用于吸入的干粉制剂 |
WO2015138352A1 (en) * | 2014-03-10 | 2015-09-17 | Tiger Tool International Incorporated | Heating and cooling systems and methods for truck cabs |
WO2015148649A2 (en) * | 2014-03-26 | 2015-10-01 | Basil Rigas | Systems and methods for ameliorating the effects of tobacco products |
US20170027963A1 (en) * | 2014-04-10 | 2017-02-02 | Patrick Crowley | Delivery of non-steroidal agents to the brain via the nasal tract to treat neurological disorders |
WO2015179772A1 (en) | 2014-05-23 | 2015-11-26 | Concert Pharmaceuticals, Inc. | Deuterated phenylquinazolinone and phenylisoquinolinone compounds |
CA2949559C (en) | 2014-06-06 | 2023-08-29 | Research Triangle Institute | Apelin receptor (apj) agonists and uses thereof |
JP2015229527A (ja) * | 2014-06-09 | 2015-12-21 | 三光機械株式会社 | 多列式自動包装機 |
US11298477B2 (en) | 2014-06-30 | 2022-04-12 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
WO2016001922A1 (en) | 2014-06-30 | 2016-01-07 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
WO2016001924A2 (en) | 2014-06-30 | 2016-01-07 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
MX2017000056A (es) | 2014-06-30 | 2017-06-30 | Syqe Medical Ltd | Dispositivo inhalador con regulacion de flujo. |
MX2017000057A (es) | 2014-06-30 | 2017-06-30 | Syqe Medical Ltd | Procedimiento y dispositivo para vaporizacion e inhalacion de sustancias aisladas. |
PL3160552T3 (pl) | 2014-06-30 | 2020-03-31 | Syqe Medical Ltd. | Wkład z dawką leku dla urządzenia inhalacyjnego |
AU2015326472B2 (en) | 2014-09-29 | 2020-05-28 | Zogenix International Limited | Control system for control of distribution of medication |
WO2016061488A1 (en) | 2014-10-17 | 2016-04-21 | Concert Pharmaceuticals, Inc. | Amine reuptake inhibitors |
WO2016073545A1 (en) | 2014-11-06 | 2016-05-12 | Concert Pharmaceuticals, Inc. | Phenyloxadiazole benzoic acids |
WO2016089814A1 (en) | 2014-12-02 | 2016-06-09 | Concert Pharmaceuticals, Inc. | Deuterated analogues of daclatasvir |
MY187877A (en) | 2014-12-23 | 2021-10-26 | Acelrx Pharmaceuticals Inc | Systems, devices and methods for dispensing oral transmucosal dosage forms |
WO2016105547A1 (en) | 2014-12-24 | 2016-06-30 | Concert Pharmaceuticals, Inc. | Deuterated dasabuvir |
WO2016109795A1 (en) | 2014-12-31 | 2016-07-07 | Concert Pharmaceuticals, Inc. | Deuterated funapide and difluorofunapide |
US20160206610A1 (en) * | 2015-01-20 | 2016-07-21 | Xoc Pharmaceuticals, Inc. | Methods for treating and/or preventing emesis and/or nausea including acute and/or delayed nausea and/or acute emesis and/or delayed emesis |
JP6856532B2 (ja) | 2015-01-20 | 2021-04-07 | エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc | エルゴリン化合物およびその使用 |
MX2017009406A (es) | 2015-01-20 | 2018-01-18 | Xoc Pharmaceuticals Inc | Compuestos de tipo isoergolina y usos de estos. |
EP3265440A1 (de) | 2015-03-06 | 2018-01-10 | Concert Pharmaceuticals Inc. | Deuteriertes emricasan |
CN114522152A (zh) | 2015-03-11 | 2022-05-24 | 艾利斯达医药品公司 | 气道中的防静电材料用于热气溶胶凝结方法的用途 |
CA2981495C (en) | 2015-03-31 | 2023-09-26 | Vertex Pharmaceuticals (Europe) Limited | Deuterated vx-661 |
CN107735135B (zh) | 2015-04-02 | 2020-06-26 | 希尔-罗姆服务私人有限公司 | 用于呼吸装置的歧管 |
US10683305B2 (en) | 2015-04-27 | 2020-06-16 | Concert Pharmaceuticals, Inc. | Deuterated OTX-015 |
EP3294298A4 (de) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin-analoga, synthese und verwendungen |
WO2017003469A1 (en) * | 2015-06-30 | 2017-01-05 | University Of South Florida | Inhibitors of the fkbp51 protein from a high-throughput drug screen and methods of use |
EP3316889A4 (de) | 2015-07-01 | 2018-11-14 | President and Fellows of Harvard College | Cortistatin-analoga sowie synthese und verwendungen davon |
US10034857B2 (en) | 2015-07-02 | 2018-07-31 | Civitas Therapeutics, Inc. | Triptan powders for pulmonary delivery |
WO2017020005A1 (en) | 2015-07-30 | 2017-02-02 | Concert Pharmaceuticals, Inc. | Morphinan compounds for use in treating agitation |
CA2994169A1 (en) | 2015-07-30 | 2017-02-02 | Concert Pharmaceuticals, Inc. | Deuterated morphinan compounds for use in treating agitation |
WO2017044897A1 (en) | 2015-09-10 | 2017-03-16 | Impel Neuropharma Inc. | In-line nasal delivery device |
US11267777B2 (en) | 2015-11-19 | 2022-03-08 | Concert Pharmaceuticals, Inc. | Deuterated EPI-743 |
AU2016366310C1 (en) | 2015-12-09 | 2021-09-09 | Research Triangle Institute | Improved apelin receptor (APJ) agonists and uses thereof |
PT3393655T (pt) * | 2015-12-22 | 2021-02-23 | Zogenix International Ltd | Composições de fenfluramina e métodos de preparação das mesmas |
KR20180095674A (ko) | 2015-12-22 | 2018-08-27 | 조게닉스 인터내셔널 리미티드 | 대사 저항성 펜플루라민 유사체 및 그 사용 방법 |
US10092036B2 (en) * | 2015-12-28 | 2018-10-09 | Rai Strategic Holdings, Inc. | Aerosol delivery device including a housing and a coupler |
EP3399972B1 (de) | 2016-01-06 | 2021-03-31 | Syqe Medical Ltd. | Niedrigdosierte therapeutische behandlung |
CN114847965A (zh) | 2016-02-01 | 2022-08-05 | 英凯达治疗公司 | 电子监测联合吸入药理学疗法管理心律失常 |
US20170216220A1 (en) * | 2016-02-03 | 2017-08-03 | Intelgenx Corp. | Loxapine film oral dosage form |
WO2017147003A1 (en) | 2016-02-26 | 2017-08-31 | Novobiotic Pharmaceuticals, Llc | Novel macrocyclic antibiotics and uses thereof |
EP3471703A4 (de) | 2016-06-15 | 2020-03-18 | The General Hospital Corporation | Metabolische markierung und molekulare erweiterung von biologischen materialien unter verwendung von bioorthogonalen reaktionen |
CN109641849B (zh) | 2016-07-04 | 2022-06-14 | 雅芳制药公司 | 氘代右美沙芬的合成方法 |
EP3490538A4 (de) | 2016-08-01 | 2020-03-18 | The Brigham and Women's Hospital, Inc. | Partikel zur verabreichung von proteinen und peptiden |
WO2018037306A1 (en) | 2016-08-24 | 2018-03-01 | Zogenix International Limited | Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same |
DE102016221705B4 (de) | 2016-11-07 | 2018-05-17 | Schaeffler Technologies AG & Co. KG | Zahnrad aus einem Zahnradverbund und Verfahren zur Herstellung eines Zahnradverbundes |
US20180185347A1 (en) * | 2016-11-16 | 2018-07-05 | Transition Therapeutics (Ireland 2) Limited | Tetrahydrocyclopenta[b]indole compounds and phosphodiesterase inhibitors for the treatment of the signs and symptoms of bhp |
SI3551189T1 (sl) | 2016-12-09 | 2024-03-29 | Alexza Pharmaceuticals, Inc. | Uporaba alprazolama pri terapiji za epilepsijo |
LT3474850T (lt) | 2017-02-02 | 2020-08-10 | Otolanum Ag | Intranazalinė kompozicija, apimanti betahistiną |
JP7152408B2 (ja) | 2017-03-10 | 2022-10-12 | キアペグ ファーマシューティカルズ アクチエボラグ | 遊離可能コンジュゲート |
ES2942889T3 (es) | 2017-03-13 | 2023-06-07 | Beyondspring Pharmaceuticals Inc | Composiciones de plinabulina y uso de las mismas |
JP2020519628A (ja) | 2017-05-10 | 2020-07-02 | インカーダ セラピューティクス, インコーポレイテッド | 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法 |
AU2018270266B2 (en) | 2017-05-19 | 2022-06-30 | Superb Wisdom Limited | Derivatives of resiquimod |
BR112019025420A2 (pt) | 2017-06-01 | 2020-06-16 | Xoc Pharmaceuticals, Inc. | Compostos policíclicos e usos destes |
US20210137898A1 (en) | 2017-06-15 | 2021-05-13 | Mayo Foundation For Medical Education And Research | Methods to treat gliomas using a stat3 inhibitor |
US11396516B2 (en) | 2017-06-16 | 2022-07-26 | The General Hospital Corporation | Tricyclic compounds as Cyp1 inhibitors |
US9993486B1 (en) | 2017-06-19 | 2018-06-12 | Tlc Therapeutics, Llc | Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability |
CN109391578B (zh) * | 2017-08-11 | 2022-07-22 | 华为技术有限公司 | 信号发送方法、信号接收方法、终端设备及网络设备 |
US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
EP3697767A4 (de) | 2017-10-16 | 2021-09-01 | Dana Farber Cancer Institute, Inc. | Verbindungen und verwendung zur behandlung von krebs |
JP7191099B2 (ja) | 2017-11-21 | 2022-12-16 | インペル ファーマシューティカルズ インコーポレイテッド | 浸漬管を備えた鼻腔内装置 |
EP3713626A4 (de) | 2017-11-21 | 2021-08-18 | Impel Neuropharma Inc. | Intranasale vorrichtung mit einlassschnittstelle |
ES2937440T3 (es) | 2018-01-05 | 2023-03-28 | Impel Pharmaceuticals Inc | Administración intranasal de dihidroergotamina mediante un dispositivo olfativo de precisión |
CA3087698A1 (en) * | 2018-01-05 | 2019-07-11 | Impel Neuropharma, Inc. | Intranasal delivery of olanzapine by precision olfactory device |
WO2019152733A1 (en) | 2018-01-31 | 2019-08-08 | Mayo Foundation For Medical Education And Research | Methods of treating fibrotic pathologies |
US10744087B2 (en) | 2018-03-22 | 2020-08-18 | Incarda Therapeutics, Inc. | Method to slow ventricular rate |
WO2019216919A1 (en) | 2018-05-11 | 2019-11-14 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
US11510903B2 (en) | 2018-07-04 | 2022-11-29 | Federico Amezcua Amezcua | Synergic pharmaceutical composition of the active enantiomer (S)-ketorolac and Gabapentin for the treatment of neuropathic pain |
KR20210029790A (ko) | 2018-07-05 | 2021-03-16 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | PIKfyve 저해제 |
WO2020018959A1 (en) | 2018-07-19 | 2020-01-23 | Impel Neuropharma, Inc. | Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease |
WO2020036478A2 (es) | 2018-08-13 | 2020-02-20 | AMÉZCUA AMÉZCUA, Federico | Composición farmacéutica sinérgica de aceclofenaco y betametasona para el tratamiento del dolor en las formas localizadas de afecciones reumáticas |
US11090449B2 (en) | 2018-08-21 | 2021-08-17 | Vivera Pharmaceuticals Inc. | Smart inhaler device with automated dose delivery, measurement, and management |
US11083850B2 (en) | 2018-08-21 | 2021-08-10 | Vivera Pharmaceuticals Inc. | Secure smart dosing system with automated delivery, measurement, and management |
WO2020053815A1 (en) | 2018-09-12 | 2020-03-19 | Quiapeg Pharmaceuticals Ab | Releasable glp-1 conjugates |
NZ777687A (en) | 2019-01-03 | 2023-12-22 | Impel Pharmaceuticals Inc | Nasal drug delivery device |
US20220112218A1 (en) | 2019-01-03 | 2022-04-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods and materials for increasing transcription factor eb polypeptide levels |
MX2019000312A (es) | 2019-01-08 | 2019-10-09 | Federico Amezcua Amezcua | Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico. |
CN109674773A (zh) * | 2019-02-22 | 2019-04-26 | 南京中医药大学 | 一种肺部给药的昔多芬药物微粒及其制备方法与应用 |
CA3140374A1 (en) | 2019-05-17 | 2020-11-26 | Impel Neuropharma, Inc. | Single-use nasal delivery device |
KR20220041847A (ko) | 2019-07-30 | 2022-04-01 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | 섬유성 병리를 치료하기 위한 화합물 및 방법 |
US11007185B2 (en) | 2019-08-01 | 2021-05-18 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
US11364225B2 (en) | 2019-08-21 | 2022-06-21 | Bn Intellectual Properties, Inc. | Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same |
US11497249B2 (en) | 2019-09-16 | 2022-11-15 | Vapor Cartridge Technology Llc | Drug delivery system with stackable substrates |
EP3868364A1 (de) | 2020-02-24 | 2021-08-25 | GH Research Limited | Aerosol enthaltend 5-methoxy-n,n-dimethyltryptamine |
US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
US11071739B1 (en) | 2020-09-29 | 2021-07-27 | Genus Lifesciences Inc. | Oral liquid compositions including chlorpromazine |
US20220117916A1 (en) * | 2020-10-19 | 2022-04-21 | SafeRx Pharmaceuticals, LLC | Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose |
EP4159192A1 (de) | 2021-09-30 | 2023-04-05 | Biomind Labs Inc | Nasenspray auf dimethyltriptaminbasis für die personalisierte behandlung von neurologischen und psychiatrischen störungen |
TW202325285A (zh) * | 2021-10-14 | 2023-07-01 | 靜岡縣公立大學法人 | 粉末製劑 |
IT202100031637A1 (it) | 2021-12-17 | 2023-06-17 | Universita’ Degli Studi Di Parma | Polveri per inalazione e procedimento di produzione |
Family Cites Families (273)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US32638A (en) * | 1861-06-25 | Boot-heel | ||
US58009A (en) * | 1866-09-11 | Improved condenser | ||
US30285A (en) * | 1860-10-09 | Fruit-drier | ||
US113557A (en) * | 1871-04-11 | Improvement in metal screws and nuts | ||
GB502761A (en) | 1938-01-29 | 1939-03-24 | Christopher Engelbreth | Improvements in and relating to hand inhalation apparatus |
US2902484A (en) | 1954-04-27 | 1959-09-01 | Rhone Poulenc Sa | Phenthiazine derivatives and processes for their preparation |
US3474101A (en) | 1960-09-05 | 1969-10-21 | Reckitt & Sons Ltd | Thebaine and oripavine derivatives |
NL284196A (de) | 1961-10-10 | |||
GB972363A (en) | 1962-08-18 | 1964-10-14 | Rambold Adolf | Wrapper band for teabag or the like |
US3169095A (en) | 1962-10-30 | 1965-02-09 | Rexall Drug Chemical | Self-propelling powder-dispensing compositions |
BE629985A (de) | 1962-11-29 | |||
GB1063512A (en) | 1962-11-30 | 1967-03-30 | Benger Lab Ltd | Aerosols |
US3456247A (en) * | 1966-01-14 | 1969-07-15 | Ibm | Coupled film storage device |
IL26896A (en) | 1966-01-19 | 1970-11-30 | Endo Lab | 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones |
US3987052A (en) | 1969-03-17 | 1976-10-19 | The Upjohn Company | 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
USRE30285E (en) | 1972-05-22 | 1980-05-27 | Spraying devices, in particular nebulizing devices | |
US3949743A (en) * | 1973-03-19 | 1976-04-13 | Schick Incorporated | Medicated vapor production method and apparatus |
US3982095A (en) | 1973-10-04 | 1976-09-21 | Searle Cardio-Pulmonary Systems Inc. | Respiratory humidifier |
US3894040A (en) | 1974-09-16 | 1975-07-08 | American Home Prod | 2,5,6,7-Tetrahydro-3H-imidazo(1,2-D)(1,4)benzodiazepine-5,6-dicarboxylic acid esters |
US4121583A (en) | 1976-07-13 | 1978-10-24 | Wen Yuan Chen | Method and apparatus for alleviating asthma attacks |
US4141369A (en) * | 1977-01-24 | 1979-02-27 | Burruss Robert P | Noncombustion system for the utilization of tobacco and other smoking materials |
SE7812207L (sv) | 1977-12-01 | 1979-06-02 | Welsh Nat School Med | Apparat, forfarande och framstellda produkter for anvendning vid administration av antihistaminer |
US4183912A (en) | 1978-01-16 | 1980-01-15 | American Home Products Corporation | Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine |
US4484451A (en) * | 1978-09-05 | 1984-11-27 | United Air Specialists, Inc. | Two-stage gas condenser with feedback cooling |
IL59407A (en) | 1979-03-06 | 1983-12-30 | Sanofi Sa | Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them |
US4654370A (en) | 1979-03-12 | 1987-03-31 | Abbott Laboratories | Glyceryl valproates |
US4229447A (en) | 1979-06-04 | 1980-10-21 | American Home Products Corporation | Intraoral methods of using benzodiazepines |
EP0039369B1 (de) | 1980-05-02 | 1983-06-15 | Schering Corporation | Beclomethason-ester-solvate, Verfahren zu ihrer Herstellung und Herstellung einer Formulierung |
US4303083A (en) | 1980-10-10 | 1981-12-01 | Burruss Jr Robert P | Device for evaporation and inhalation of volatile compounds and medications |
US4376767A (en) | 1981-01-02 | 1983-03-15 | Merck & Co., Inc. | Pyridylmethyl esters of selected bio-affecting carboxylic acids |
DE3116951C2 (de) * | 1981-04-29 | 1984-12-20 | Drägerwerk AG, 2400 Lübeck | Vorrichtung zur Beimischung flüssiger Narkosemittel in das dem Patienten zuzuführende Atemgas |
DE3224849A1 (de) | 1982-07-02 | 1984-01-05 | Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn | Dampfinhaliergeraet |
US4508726A (en) | 1982-09-16 | 1985-04-02 | The Upjohn Company | Treatment of panic disorders with alprazolam |
EP0120968B1 (de) | 1982-09-30 | 1988-06-29 | Dainihon Jochugiku Co., Ltd. | Vorrichtung zur heissverflüchtigung eines medizinischen agenz |
US4474191A (en) | 1982-09-30 | 1984-10-02 | Steiner Pierre G | Tar-free smoking devices |
US4753758A (en) | 1983-05-19 | 1988-06-28 | Intertech Resources Inc. | Respiratory humidifier |
DE3326089A1 (de) | 1983-07-20 | 1985-02-07 | Gödecke AG, 1000 Berlin | Zur inhalation bestimmte darreichungsform von calcium-antagonisten |
DE3476197D1 (en) | 1983-08-01 | 1989-02-23 | Mclean Hospital Corp | Gaba esters and gaba analogue esters |
US4588721A (en) | 1983-09-12 | 1986-05-13 | The Upjohn Company | Treatment of negative symptoms of schizophrenia |
US4566552A (en) * | 1983-11-16 | 1986-01-28 | International Harvester Company | Hood tilt retardation system |
US4683231A (en) | 1984-03-02 | 1987-07-28 | Research Foundation For Mental Hygiene, Inc. | Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking |
US4793365A (en) | 1984-09-14 | 1988-12-27 | R. J. Reynolds Tobacco Company | Smoking article |
US5020548A (en) | 1985-08-26 | 1991-06-04 | R. J. Reynolds Tobacco Company | Smoking article with improved fuel element |
US4854331A (en) | 1984-09-14 | 1989-08-08 | R. J. Reynolds Tobacco Company | Smoking article |
US5067499A (en) | 1984-09-14 | 1991-11-26 | R. J. Reynolds Tobacco Company | Smoking article |
US5042509A (en) | 1984-09-14 | 1991-08-27 | R. J. Reynolds Tobacco Company | Method for making aerosol generating cartridge |
CN1018607B (zh) | 1984-12-21 | 1992-10-14 | 美国耳·杰·瑞诺兹烟草公司 | 吸烟制品 |
US4928714A (en) | 1985-04-15 | 1990-05-29 | R. J. Reynolds Tobacco Company | Smoking article with embedded substrate |
JPS63500175A (ja) | 1985-05-22 | 1988-01-21 | リポソ−ム テクノロジ−,インコ−ポレイテツド | リポソ−ム吸入法および吸入システム |
US4989619A (en) | 1985-08-26 | 1991-02-05 | R. J. Reynolds Tobacco Company | Smoking article with improved fuel element |
US4756318A (en) | 1985-10-28 | 1988-07-12 | R. J. Reynolds Tobacco Company | Smoking article with tobacco jacket |
US5060666A (en) | 1985-10-28 | 1991-10-29 | R. J. Reynolds Tobacco Company | Smoking article with tobacco jacket |
US5033483A (en) | 1985-10-28 | 1991-07-23 | R. J. Reynolds Tobacco Company | Smoking article with tobacco jacket |
JPS62204756A (ja) * | 1986-03-04 | 1987-09-09 | 大研医工株式会社 | 薬剤揮散方法および装置 |
EP0259383B1 (de) | 1986-03-10 | 1991-01-23 | Kurt Dr. Burghart | Pharmazeutikum sowie verfahren zu seiner herstellung |
US4708151A (en) | 1986-03-14 | 1987-11-24 | R. J. Reynolds Tobacco Company | Pipe with replaceable cartridge |
US4771795A (en) | 1986-05-15 | 1988-09-20 | R. J. Reynolds Tobacco Company | Smoking article with dual burn rate fuel element |
US4917120A (en) | 1986-05-21 | 1990-04-17 | Advanced Tobacco Products, Inc. | Nicotine impact modification |
US4735217A (en) * | 1986-08-21 | 1988-04-05 | The Procter & Gamble Company | Dosing device to provide vaporized medicament to the lungs as a fine aerosol |
US4858630A (en) | 1986-12-08 | 1989-08-22 | R. J. Reynolds Tobacco Company | Smoking article with improved aerosol forming substrate |
US4734560A (en) | 1987-01-20 | 1988-03-29 | Medical Enterprises, Ltd. | Vaporizing unit |
US4819665A (en) | 1987-01-23 | 1989-04-11 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US4924883A (en) | 1987-03-06 | 1990-05-15 | R. J. Reynolds Tobacco Company | Smoking article |
US5017575A (en) | 1987-06-09 | 1991-05-21 | Golwyn Daniel H | Treatment of immunologically based disorders, specifically Crohn's disease |
GB8713645D0 (en) | 1987-06-11 | 1987-07-15 | Imp Tobacco Ltd | Smoking device |
US5019122A (en) | 1987-08-21 | 1991-05-28 | R. J. Reynolds Tobacco Company | Smoking article with an enclosed heat conductive capsule containing an aerosol forming substance |
US4906417A (en) | 1988-02-08 | 1990-03-06 | Associated Mills Inc. | Humidifier |
US4853517A (en) | 1988-03-28 | 1989-08-01 | John G. Bowen | Vaporizing unit |
US4906119A (en) * | 1988-04-14 | 1990-03-06 | Lloyd Hartford | Handwriting stabilizer |
DE3815221C2 (de) | 1988-05-04 | 1995-06-29 | Gradinger F Hermes Pharma | Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen |
US4881556A (en) | 1988-06-06 | 1989-11-21 | R. J. Reynolds Tobacco Company | Low CO smoking article |
US5345951A (en) * | 1988-07-22 | 1994-09-13 | Philip Morris Incorporated | Smoking article |
EP0358114A3 (de) | 1988-09-08 | 1990-11-14 | R.J. Reynolds Tobacco Company | Elektrisches Gerät zur Verabreichung von Aerosol |
US4947874A (en) | 1988-09-08 | 1990-08-14 | R. J. Reynolds Tobacco Company | Smoking articles utilizing electrical energy |
US4922901A (en) | 1988-09-08 | 1990-05-08 | R. J. Reynolds Tobacco Company | Drug delivery articles utilizing electrical energy |
US4947875A (en) | 1988-09-08 | 1990-08-14 | R. J. Reynolds Tobacco Company | Flavor delivery articles utilizing electrical energy |
US4950664A (en) | 1988-09-16 | 1990-08-21 | Rugby-Darby Group Companies, Inc. | Nasal administration of benzodiazepine hypnotics |
USRE36744E (en) | 1988-09-16 | 2000-06-20 | Ribogene, Inc. | Nasal administration of benzodiazepine hypnotics |
US4963289A (en) * | 1988-09-19 | 1990-10-16 | The United States Of America As Represented By The United States Department Of Energy | Method for producing monodisperse aerosols |
US5511726A (en) | 1988-09-23 | 1996-04-30 | Battelle Memorial Institute | Nebulizer device |
US4917119A (en) | 1988-11-30 | 1990-04-17 | R. J. Reynolds Tobacco Company | Drug delivery article |
US4906476A (en) | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
GB8900267D0 (en) | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
DE3908161A1 (de) * | 1989-03-13 | 1990-09-27 | Bat Cigarettenfab Gmbh | Rauchbarer artikel |
JP3062760B2 (ja) * | 1989-03-14 | 2000-07-12 | コニカ株式会社 | 複合レンズ |
EP0470154B1 (de) | 1989-04-28 | 1996-06-05 | Riker Laboratories, Inc. | Inhalationsvorrichtung für trockenpulver |
HUT60631A (en) | 1989-05-05 | 1992-10-28 | North Sydney Area Health Serv | Process for producing pharmaceutical compositions suitable for increasing fertility |
ATE93596T1 (de) * | 1989-05-17 | 1993-09-15 | Leifeld Gmbh & Co | Verfahren zur herstellung einer riemenscheibe. |
US4941483A (en) | 1989-09-18 | 1990-07-17 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US6048857A (en) | 1989-10-17 | 2000-04-11 | Ellinwood, Jr.; Everett H. | Dosing method of administering medicaments via inhalation administration |
US6313176B1 (en) | 1989-10-17 | 2001-11-06 | Everett J. Ellinwood, Jr. | Dosing method of administering deprenyl via intraoral administration or inhalation administration |
US5707644A (en) * | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
US5224498A (en) * | 1989-12-01 | 1993-07-06 | Philip Morris Incorporated | Electrically-powered heating element |
US5144962A (en) * | 1989-12-01 | 1992-09-08 | Philip Morris Incorporated | Flavor-delivery article |
US5060671A (en) * | 1989-12-01 | 1991-10-29 | Philip Morris Incorporated | Flavor generating article |
CA2070823C (en) | 1989-12-05 | 1999-01-12 | William H. Ii Frey | Neurologic agents for nasal administration to the brain |
GB2239807A (en) | 1990-01-09 | 1991-07-17 | Boc Group Plc | Anaesthetic vaporiser |
US5376386A (en) * | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
US5099861A (en) | 1990-02-27 | 1992-03-31 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US5366770A (en) | 1990-04-17 | 1994-11-22 | Xingwu Wang | Aerosol-plasma deposition of films for electronic cells |
US5455043A (en) | 1990-06-13 | 1995-10-03 | Fischel-Ghodsian; Fariba | Device for controlled release of vaporous medications through nasal route |
US5126123A (en) | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
EP0469797B2 (de) | 1990-08-02 | 2001-12-12 | Datex-Ohmeda Inc. | Narkosemittelverdampfer |
US5292499A (en) | 1990-09-11 | 1994-03-08 | University Of Wales College Of Cardiff | Method of preparing medical aerosol formulations including drug dissolved in reverse micelles |
US5166202A (en) | 1990-09-19 | 1992-11-24 | Trustees Of The University Of Pennsylvania | Method for the treatment of panic disorder |
US5343226A (en) * | 1990-09-28 | 1994-08-30 | Dataproducts Corporation | Ink jet ink supply apparatus |
US5175152A (en) | 1990-09-28 | 1992-12-29 | Singh Nikhilesh N | Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form |
DE69229070T2 (de) | 1991-02-09 | 1999-11-18 | B S D Bio Science Dev Snc Di O | Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation |
US5993805A (en) | 1991-04-10 | 1999-11-30 | Quadrant Healthcare (Uk) Limited | Spray-dried microparticles and their use as therapeutic vehicles |
US5457100A (en) | 1991-12-02 | 1995-10-10 | Daniel; David G. | Method for treatment of recurrent paroxysmal neuropsychiatric |
US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
US5622944A (en) | 1992-06-12 | 1997-04-22 | Affymax Technologies N.V. | Testosterone prodrugs for improved drug delivery |
ATE204750T1 (de) | 1992-06-12 | 2001-09-15 | Teijin Ltd | Pharmazeutische zubereitung zur anwendung in den atemwegen |
US5607691A (en) | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
US5284133A (en) * | 1992-07-23 | 1994-02-08 | Armstrong Pharmaceuticals, Inc. | Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means |
AU5358694A (en) * | 1992-10-28 | 1994-05-24 | Charles A. Rosen | Method and devices for delivering drugs by inhalation |
US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
US5915378A (en) | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
US5724957A (en) | 1993-01-29 | 1998-03-10 | Aradigm Corporation | Intrapulmonary delivery of narcotics |
US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
US5694919A (en) | 1993-01-29 | 1997-12-09 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activated dispenser |
US5507277A (en) | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
US5672581A (en) | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US5357257A (en) * | 1993-04-05 | 1994-10-18 | General Electric Company | Apparatus and method for equalizing channels in a multi-channel communication system |
US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
US5666977A (en) * | 1993-06-10 | 1997-09-16 | Philip Morris Incorporated | Electrical smoking article using liquid tobacco flavor medium delivery system |
KR100314138B1 (ko) | 1993-06-29 | 2001-12-28 | 마틴 보게스 로버트 | 정량분배장치 |
US5388574A (en) | 1993-07-29 | 1995-02-14 | Ingebrethsen; Bradley J. | Aerosol delivery article |
DE4328243C1 (de) | 1993-08-19 | 1995-03-09 | Sven Mielordt | Rauch- oder Inhalationsvorrichtung |
US5456247A (en) | 1993-08-26 | 1995-10-10 | Iowa State University Research Foundation, Inc. | Method for delivering drugs soluble in a vaporization vehicle |
FI98270C (fi) * | 1993-11-29 | 1997-05-26 | Instrumentarium Oy | Menetelmä ja sovitelma anesteetin höyrystämisen yhteydessä |
US5543434A (en) | 1994-02-25 | 1996-08-06 | Weg; Stuart L. | Nasal administration of ketamine to manage pain |
US5451408A (en) | 1994-03-23 | 1995-09-19 | Liposome Pain Management, Ltd. | Pain management with liposome-encapsulated analgesic drugs |
US6102036A (en) | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
WO1995031182A1 (en) | 1994-05-13 | 1995-11-23 | Aradigm Corporation | Narcotic containing aerosol formulation |
US5522385A (en) | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
AU3745795A (en) | 1994-10-14 | 1996-05-06 | Glaxo Wellcome S.P.A. | Use of CCK-B receptor antagonists for the treatment of sleepdisorders |
EP1177807A3 (de) | 1994-10-28 | 2003-10-22 | Aradigm Corporation | Vorrichtung und Verfahren zum Herstellen von Aerosolnebel aus einem atmungserleichternden Arzneimittel |
US5767117A (en) | 1994-11-18 | 1998-06-16 | The General Hospital Corporation | Method for treating vascular headaches |
JPH11502845A (ja) | 1995-03-31 | 1999-03-09 | アラディグム コーポレーション | 造血剤の肺内輸送 |
US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US6258341B1 (en) | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
DE19519056A1 (de) | 1995-05-24 | 1997-01-16 | Klinge Co Chem Pharm Fab | Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation |
US5874481A (en) | 1995-06-07 | 1999-02-23 | Alliance Pharmaceutical Corp. | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents |
US6245347B1 (en) | 1995-07-28 | 2001-06-12 | Zars, Inc. | Methods and apparatus for improved administration of pharmaceutically active compounds |
JPH0943487A (ja) | 1995-08-01 | 1997-02-14 | Fuji Photo Film Co Ltd | ズームレンズ |
US5649554A (en) * | 1995-10-16 | 1997-07-22 | Philip Morris Incorporated | Electrical lighter with a rotatable tobacco supply |
WO1997016181A1 (en) | 1995-11-03 | 1997-05-09 | University Of Kentucky | Method for the intranasal administration of l-dopa prodrugs |
US6017963A (en) | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
US5564442A (en) | 1995-11-22 | 1996-10-15 | Angus Collingwood MacDonald | Battery powered nicotine vaporizer |
US6041777A (en) * | 1995-12-01 | 2000-03-28 | Alliance Pharmaceutical Corp. | Methods and apparatus for closed-circuit ventilation therapy |
DE69632148T2 (de) | 1995-12-14 | 2005-03-17 | Taisho Pharmaceutical Co., Ltd. | Aerosolzubereitung |
SE9504580L (sv) | 1995-12-21 | 1997-06-22 | Siemens Elema Ab | Förfarande vid förgasning av en narkosvätska och en förgasare |
EP0955885A1 (de) | 1996-02-05 | 1999-11-17 | Aradigm Corporation | Lüftungsbilderzeugung mit hilfe eines feinpartikel aerosolgenerators |
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US5927124A (en) * | 1996-03-05 | 1999-07-27 | Adaptive Motion Control Systems, Inc. | Apparatus for bending and cutting tubing, and method of using same |
GB9606188D0 (en) * | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
GB9606677D0 (en) | 1996-03-29 | 1996-06-05 | Glaxo Wellcome Inc | Process and device |
JP2000510109A (ja) * | 1996-04-29 | 2000-08-08 | デュラ・ファーマシューティカルズ・インコーポレイテッド | 乾燥粉末の吸入方法 |
US5743251A (en) | 1996-05-15 | 1998-04-28 | Philip Morris Incorporated | Aerosol and a method and apparatus for generating an aerosol |
US5855913A (en) * | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
GB9613015D0 (en) | 1996-06-21 | 1996-08-28 | Reckitt & Colman Inc | Device |
KR20000022239A (ko) | 1996-07-11 | 2000-04-25 | 토마스 헤인 | 인돌 선택성 세로토닌 작용약을 함유한 내포 복합체 |
US6694975B2 (en) * | 1996-11-21 | 2004-02-24 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
US5906202A (en) | 1996-11-21 | 1999-05-25 | Aradigm Corporation | Device and method for directing aerosolized mist to a specific area of the respiratory tract |
US6131570A (en) | 1998-06-30 | 2000-10-17 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
ATE287257T1 (de) | 1997-01-16 | 2005-02-15 | Massachusetts Inst Technology | Zubereitung von partikelhaltigen arzneimitteln zur inhalation |
US6461591B1 (en) | 1997-02-05 | 2002-10-08 | Jago Research Ag | Medical aerosol formulations |
US5829435A (en) | 1997-02-24 | 1998-11-03 | Aradigm Corporation | Prefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particles |
US5837713A (en) | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
KR100289448B1 (ko) * | 1997-07-23 | 2001-05-02 | 미즈노 마사루 | 향미발생장치 |
US5874841A (en) * | 1997-07-28 | 1999-02-23 | Philips Electronics North America Corporation | Sample-and-hold circuit for a switched-mode power supply |
US6090212A (en) | 1997-08-15 | 2000-07-18 | Micro C Technologies, Inc. | Substrate platform for a semiconductor substrate during rapid high temperature processing and method of supporting a substrate |
EP1019023B1 (de) | 1997-09-29 | 2003-05-07 | Inhale Therapeutic Systems, Inc. | In verneblern verwendbare, stabilisierte zubereitungen |
US6403597B1 (en) * | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US5915841A (en) * | 1998-01-05 | 1999-06-29 | Capstone Turbine Corporation | Compliant foil fluid film radial bearing |
US20020006181A1 (en) | 1998-01-23 | 2002-01-17 | Mackenzie Innes K. | Method and device for estimating bone mineral content of the calcaneus |
US6158431A (en) * | 1998-02-13 | 2000-12-12 | Tsi Incorporated | Portable systems and methods for delivery of therapeutic material to the pulmonary system |
CA2322805C (en) | 1998-03-05 | 2005-09-13 | Nippon Shinyaku Co., Ltd. | Fat emulsions for inhalational administration |
DE1073432T1 (de) | 1998-04-14 | 2002-02-07 | Gen Hospital Corp | Verwendung von glycinrezeptoragonisten und glycinaufnahmeinhibitoren zur behandlung neuropsychiatrischer beschwerden |
AU4680699A (en) | 1998-06-12 | 1999-12-30 | Aradigm Corporation | Methods of delivering aerosolized polynucleotides to the respiratory tract |
US6095153A (en) | 1998-06-19 | 2000-08-01 | Kessler; Stephen B. | Vaporization of volatile materials |
TWI223598B (en) | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
WO2000000215A1 (en) | 1998-06-29 | 2000-01-06 | Inhale Therapeutic Systems, Inc. | Particulate delivery systems and methods of use |
GB9814172D0 (en) | 1998-06-30 | 1998-08-26 | Andaris Ltd | Formulation for inhalation |
MA25590A1 (fr) * | 1998-09-14 | 2002-12-31 | Inhale Therapeutic Syst | Agent actif de delivraison de poudre seche |
US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
US6509005B1 (en) | 1998-10-27 | 2003-01-21 | Virginia Commonwealth University | Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler |
US6255334B1 (en) * | 1998-10-30 | 2001-07-03 | Pfizer Inc | 5HT 1 receptor agonists and metoclopramide for the treatment of migraine |
US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
MXPA01004828A (es) | 1998-11-12 | 2002-09-18 | Frank G Pilkiewicz | Sistema de inhalacion. |
DK1283036T3 (da) | 1998-11-13 | 2008-03-25 | Jagotec Ag | Törpulver til inhalation |
US6070575A (en) | 1998-11-16 | 2000-06-06 | Aradigm Corporation | Aerosol-forming porous membrane with certain pore structure |
ATE251447T1 (de) | 1998-12-11 | 2003-10-15 | Pharmachemie Bv | Pharmazeutische zubereitungen zur inhalation eines opioids |
US6376550B1 (en) | 1999-02-09 | 2002-04-23 | Asta Medica Ag | Pharmaceutical compositions containing tramadol for migraine |
WO2000047203A1 (en) | 1999-02-12 | 2000-08-17 | Mqs, Inc. | Formulation and system for intra-oral delivery of pharmaceutical agents |
US6591839B2 (en) * | 1999-02-17 | 2003-07-15 | Dieter Meyer | Filter material for reducing harmful substances in tobacco smoke |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
EP1173482A1 (de) | 1999-04-27 | 2002-01-23 | Eli Lilly And Company | Insulinkristalle zur aufnahme über die lunge |
BR0010262A (pt) | 1999-05-03 | 2002-01-15 | Battelle Memorial Institute | Composição para formar um aerossol, processo de preparação e de aerossolização de uma composição, e, dispositivo gerador de aerossol |
US6428769B1 (en) | 1999-05-04 | 2002-08-06 | Aradigm Corporation | Acute testosterone administration |
GB9912356D0 (en) * | 1999-05-26 | 1999-07-28 | Btg Int Ltd | Generation of microfoam |
KR100883477B1 (ko) | 1999-05-27 | 2009-02-16 | 아쿠스피어 인코포레이티드. | 다공성 약물 매트릭스의 약제 조성물 |
EP1192009B1 (de) | 1999-06-11 | 2013-05-01 | Aradigm Corporation | Verfahren zur erzeugung eines aerosols |
US20020061281A1 (en) | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
WO2001005459A1 (en) | 1999-07-16 | 2001-01-25 | Aradigm Corporation | System for effecting smoke cessation |
GB2368283A (en) * | 1999-08-13 | 2002-05-01 | Vela Pharmaceuticals Inc | Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof |
WO2001013957A2 (en) | 1999-08-24 | 2001-03-01 | Cellgate, Inc. | Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
WO2001017614A2 (en) | 1999-09-07 | 2001-03-15 | Conjuchem, Inc. | Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
CZ20021086A3 (cs) | 1999-09-30 | 2002-10-16 | Neurogen Corporation | Alkylendiaminem substituované heterocykly |
WO2001028354A1 (fr) * | 1999-10-19 | 2001-04-26 | Agromedic Co., Ltd. | Procede d'alimentation de truies reproductrices et aliments pour truies reproductrices |
IL149085A0 (en) | 1999-10-29 | 2002-11-10 | Inhale Therapeutic Syst | A dry powder composition containing a di or tripeptide |
CA2325106A1 (en) | 1999-12-06 | 2001-06-06 | Stanley L. Gore | Compositions and methods for intranasal delivery of active agents to the brain |
US6853310B2 (en) * | 1999-12-29 | 2005-02-08 | Ge Medical Systems Information Technologies, Inc. | Tri-mode medical telemetry antenna system |
AU3400501A (en) * | 2000-02-28 | 2001-09-12 | Vectura Ltd | Improvements in or relating to the delivery of oral drugs |
IL151614A0 (en) * | 2000-04-07 | 2003-04-10 | Tap Holdings Inc | Apomorphine derivatives and methods for their use |
US6632047B2 (en) | 2000-04-14 | 2003-10-14 | Board Of Regents, The University Of Texas System | Heater element for use in an in situ thermal desorption soil remediation system |
MY136453A (en) * | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
CA2410577A1 (en) | 2000-05-23 | 2001-12-13 | The Trustees Of Columbia University In The City Of New York | Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
WO2001095903A1 (en) | 2000-06-15 | 2001-12-20 | Respiratorius Ab | 5-ht3 receptor antagonists for treatment of disorders involving airway constriction |
GB0015981D0 (en) | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
FR2812545B1 (fr) | 2000-08-03 | 2003-03-28 | Air Liquide Sante Int | Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur |
US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US20020117175A1 (en) * | 2000-10-27 | 2002-08-29 | Kottayil S. George | Thermal vaporizing device for drug delivery |
EP1383376A4 (de) * | 2001-03-19 | 2006-03-08 | Praecis Pharm Inc | Pharmazeutische formulierungen für die anhaltende wirkstofffreigabe |
US20030004142A1 (en) * | 2001-04-18 | 2003-01-02 | Prior Christopher P. | Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway |
US7645442B2 (en) * | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US20030118512A1 (en) * | 2001-10-30 | 2003-06-26 | Shen William W. | Volatilization of a drug from an inclusion complex |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
US6759029B2 (en) * | 2001-05-24 | 2004-07-06 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan and zolmitriptan through an inhalation route |
US20080038363A1 (en) * | 2001-05-24 | 2008-02-14 | Zaffaroni Alejandro C | Aerosol delivery system and uses thereof |
US20070122353A1 (en) * | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US7458374B2 (en) * | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
US20030131843A1 (en) * | 2001-11-21 | 2003-07-17 | Lu Amy T. | Open-celled substrates for drug delivery |
EP1392262A1 (de) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Verabreichung von arzneimittel-estern durch inhalation |
EP1392260A2 (de) | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Verabreichung von benzodiazepinen durch inhalation |
US7090830B2 (en) * | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US6805853B2 (en) * | 2001-11-09 | 2004-10-19 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
US7498019B2 (en) * | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
US7585493B2 (en) * | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
CA2447519C (en) * | 2001-05-24 | 2008-09-16 | Alexza Molecular Delivery Corporation | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
EP1446102A1 (de) * | 2001-11-21 | 2004-08-18 | Alexza Molecular Delivery Corporation | Verabreichung von koffein durch inhalation |
AU2002361742A1 (en) * | 2001-12-18 | 2003-06-30 | Alexza Molecular Delivery Corporation | Parental analgesic formulations comprising fentanyl and a cannabinoid receptor agonist |
US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
US6772756B2 (en) * | 2002-02-09 | 2004-08-10 | Advanced Inhalation Revolutions Inc. | Method and system for vaporization of a substance |
WO2003094900A1 (en) * | 2002-05-13 | 2003-11-20 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
US20060193788A1 (en) * | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
US7074806B2 (en) * | 2002-06-06 | 2006-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
US7485143B2 (en) * | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
KR100459905B1 (ko) * | 2002-11-21 | 2004-12-03 | 삼성전자주식회사 | 두 개의 잉크챔버 사이에 배치된 히터를 가진 일체형잉크젯 프린트헤드 및 그 제조방법 |
JP2006514934A (ja) * | 2002-11-26 | 2006-05-18 | アレックザ ファーマシューティカルズ, インコーポレイテッド | 疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用 |
US20040105818A1 (en) * | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
AU2003295823B2 (en) * | 2002-11-26 | 2009-11-05 | Alexza Pharmaceuticals, Inc. | Treatment of headache with antipsychotics delivered by inhalation |
US7913688B2 (en) * | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
JP2007516404A (ja) * | 2003-05-21 | 2007-06-21 | アレックザ ファーマシューティカルズ, インコーポレイテッド | 光学点火されたかまたは電気点火された内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット |
US20050037506A1 (en) * | 2003-08-04 | 2005-02-17 | Alexza Molecular Delivery Corporation | Methods of determining film thicknesses for an aerosol delivery article |
CA2534566A1 (en) * | 2003-08-04 | 2005-02-24 | Alexza Pharmaceuticals, Inc. | Substrates for drug delivery device and methods of preparing and use |
WO2005061033A1 (en) * | 2003-12-15 | 2005-07-07 | Alexza Pharmaceuticals, Inc. | Treatment of breakthrough pain by drug aerosol inhalation |
WO2005059804A2 (en) * | 2003-12-16 | 2005-06-30 | Alexza Pharmaceuticals, Inc. | Methods for monitoring severity of panic attacks and other rapidly evolving medical events in real-time |
US7402777B2 (en) * | 2004-05-20 | 2008-07-22 | Alexza Pharmaceuticals, Inc. | Stable initiator compositions and igniters |
US7540286B2 (en) * | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
US20060032496A1 (en) * | 2004-08-12 | 2006-02-16 | Alexza Molecular Delivery Corporation | Inhalation actuated percussive ignition system |
EP1781360A1 (de) * | 2004-08-12 | 2007-05-09 | Alexza Pharmaceuticals, Inc. | Aerosol-arzneiabgabevorrichtung mit perkussiv aktivierten wärmepackungen |
EP1809240A4 (de) * | 2004-10-12 | 2010-06-16 | Alexza Pharmaceuticals Inc | Herzsichere schnelle arzneiverabreichung |
MX2008012064A (es) * | 2006-03-23 | 2008-12-17 | Amgen Inc | Compuestos de amida 1-fenilsulfonil-diaza-heterociclica y sus usos como moduladores de hidroxiesteroide deshidrogenadas. |
US20080299048A1 (en) | 2006-12-22 | 2008-12-04 | Alexza Pharmaceuticals, Inc. | Mixed drug aerosol compositions |
WO2008112661A2 (en) | 2007-03-09 | 2008-09-18 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
WO2008134668A2 (en) | 2007-04-27 | 2008-11-06 | Alexza Pharmaceuticals, Inc. | Heat-labile prodrugs |
-
2002
- 2002-05-13 EP EP02741994A patent/EP1392262A1/de not_active Withdrawn
- 2002-05-13 CA CA002446904A patent/CA2446904A1/en not_active Abandoned
- 2002-05-13 JP JP2003530268A patent/JP2005503425A/ja active Pending
- 2002-05-13 US US10/146,516 patent/US6737042B2/en not_active Expired - Fee Related
- 2002-05-15 AU AU2002314784A patent/AU2002314784A1/en not_active Abandoned
- 2002-05-15 US US10/150,268 patent/US6780399B2/en not_active Expired - Fee Related
- 2002-05-15 US US10/150,267 patent/US6797259B2/en not_active Expired - Fee Related
- 2002-05-16 EP EP02729255A patent/EP1389095A1/de not_active Withdrawn
- 2002-05-16 US US10/151,596 patent/US6855310B2/en not_active Expired - Fee Related
- 2002-05-16 US US10/151,626 patent/US6783753B2/en not_active Expired - Lifetime
- 2002-05-17 EP EP02771848A patent/EP1392264B1/de not_active Expired - Lifetime
- 2002-05-17 ES ES02729235T patent/ES2312571T3/es not_active Expired - Lifetime
- 2002-05-17 JP JP2002590949A patent/JP4578772B2/ja not_active Expired - Fee Related
- 2002-05-17 US US10/150,591 patent/US6780400B2/en not_active Expired - Lifetime
- 2002-05-17 EP EP08014271A patent/EP1987823B1/de not_active Expired - Lifetime
- 2002-05-17 DE DE60235851T patent/DE60235851D1/de not_active Expired - Lifetime
- 2002-05-17 AT AT02729235T patent/ATE406878T1/de active
- 2002-05-17 CA CA002446990A patent/CA2446990C/en not_active Expired - Fee Related
- 2002-05-17 AT AT02771848T patent/ATE401064T1/de not_active IP Right Cessation
- 2002-05-17 EP EP02729235A patent/EP1389094B1/de not_active Expired - Lifetime
- 2002-05-17 US US10/150,857 patent/US6716415B2/en not_active Expired - Lifetime
- 2002-05-17 AT AT08014271T patent/ATE462420T1/de not_active IP Right Cessation
- 2002-05-17 ES ES08014271T patent/ES2341594T3/es not_active Expired - Lifetime
- 2002-05-17 NZ NZ529422A patent/NZ529422A/en unknown
- 2002-05-20 EP EP08014272A patent/EP1990046B1/de not_active Expired - Lifetime
- 2002-05-20 DE DE60228232T patent/DE60228232D1/de not_active Expired - Lifetime
- 2002-05-20 JP JP2002590955A patent/JP4578773B2/ja not_active Expired - Lifetime
- 2002-05-20 ES ES02737053T patent/ES2311607T3/es not_active Expired - Lifetime
- 2002-05-20 CA CA002446917A patent/CA2446917C/en not_active Expired - Lifetime
- 2002-05-20 EP EP02737053A patent/EP1389098B1/de not_active Expired - Lifetime
- 2002-05-20 DE DE60235852T patent/DE60235852D1/de not_active Expired - Lifetime
- 2002-05-20 US US10/153,139 patent/US6814954B2/en not_active Expired - Lifetime
- 2002-05-20 AU AU2002310015A patent/AU2002310015B2/en not_active Expired
- 2002-05-20 PL PL02363996A patent/PL363996A1/xx unknown
- 2002-05-20 WO PCT/US2002/016118 patent/WO2002094236A1/en active Application Filing
- 2002-05-20 EP EP02737054A patent/EP1389099A1/de not_active Withdrawn
- 2002-05-20 ES ES08014272T patent/ES2341392T3/es not_active Expired - Lifetime
- 2002-05-20 US US10/152,640 patent/US6743415B2/en not_active Expired - Fee Related
- 2002-05-20 NZ NZ529419A patent/NZ529419A/en unknown
- 2002-05-20 AT AT08014272T patent/ATE462421T1/de not_active IP Right Cessation
- 2002-05-20 US US10/152,639 patent/US6716416B2/en not_active Expired - Lifetime
- 2002-05-20 AT AT02737053T patent/ATE404173T1/de active
- 2002-05-20 AT AT02731896T patent/ATE404184T1/de not_active IP Right Cessation
- 2002-05-20 MX MXPA03010703A patent/MXPA03010703A/es active IP Right Grant
- 2002-05-20 PT PT02737053T patent/PT1389098E/pt unknown
- 2002-05-20 EP EP02731896A patent/EP1389097B1/de not_active Expired - Lifetime
- 2002-05-20 DK DK02737053T patent/DK1389098T3/da active
- 2002-05-20 US US10/152,652 patent/US6740307B2/en not_active Expired - Fee Related
- 2002-05-21 JP JP2002590964A patent/JP2004535403A/ja active Pending
- 2002-05-21 EP EP02731894A patent/EP1389096B9/de not_active Expired - Lifetime
- 2002-05-21 CA CA002447521A patent/CA2447521C/en not_active Expired - Fee Related
- 2002-05-21 NZ NZ529420A patent/NZ529420A/en unknown
- 2002-05-21 AT AT02731894T patent/ATE425746T1/de active
- 2002-05-21 PT PT02731894T patent/PT1389096E/pt unknown
- 2002-05-21 NZ NZ529421A patent/NZ529421A/en unknown
- 2002-05-21 US US10/153,831 patent/US6740308B2/en not_active Expired - Lifetime
- 2002-05-21 ES ES02731894T patent/ES2324023T3/es not_active Expired - Lifetime
- 2002-05-21 US US10/153,839 patent/US6776978B2/en not_active Expired - Lifetime
- 2002-05-21 AU AU2002303833A patent/AU2002303833B2/en not_active Ceased
- 2002-05-21 US US10/153,311 patent/US6884408B2/en not_active Expired - Fee Related
- 2002-05-21 EP EP02731930A patent/EP1392257B1/de not_active Expired - Lifetime
- 2002-05-21 AT AT02731930T patent/ATE401063T1/de not_active IP Right Cessation
- 2002-05-21 CA CA002446916A patent/CA2446916C/en not_active Expired - Fee Related
- 2002-05-22 JP JP2002590938A patent/JP2004531556A/ja active Pending
- 2002-05-22 EP EP02737132A patent/EP1392259B1/de not_active Expired - Lifetime
- 2002-05-22 PL PL02363997A patent/PL363997A1/xx not_active Application Discontinuation
- 2002-05-22 DE DE60220909T patent/DE60220909T2/de not_active Expired - Lifetime
- 2002-05-22 CA CA002447166A patent/CA2447166C/en not_active Expired - Fee Related
- 2002-05-22 AT AT02737132T patent/ATE365548T1/de not_active IP Right Cessation
- 2002-05-22 US US10/155,705 patent/US6805854B2/en not_active Expired - Fee Related
- 2002-05-22 US US10/155,703 patent/US6803031B2/en not_active Expired - Fee Related
- 2002-05-22 NZ NZ529418A patent/NZ529418A/en unknown
- 2002-05-23 EP EP02737120A patent/EP1390021B1/de not_active Expired - Lifetime
- 2002-05-23 EP EP02739410A patent/EP1392261B1/de not_active Expired - Lifetime
- 2002-05-23 NZ NZ529416A patent/NZ529416A/en unknown
- 2002-05-23 MX MXPA03010702A patent/MXPA03010702A/es active IP Right Grant
- 2002-05-23 AT AT02737120T patent/ATE418330T1/de not_active IP Right Cessation
- 2002-05-23 US US10/154,594 patent/US6740309B2/en not_active Expired - Fee Related
- 2002-05-23 US US10/154,765 patent/US6814955B2/en not_active Expired - Fee Related
- 2002-05-23 AT AT02739410T patent/ATE418971T1/de not_active IP Right Cessation
- 2002-05-23 PL PL02364002A patent/PL364002A1/xx unknown
- 2002-05-23 CA CA2447099A patent/CA2447099C/en not_active Expired - Fee Related
- 2002-05-23 JP JP2002590960A patent/JP2004532860A/ja active Pending
- 2002-05-23 US US10/155,097 patent/US6716417B2/en not_active Expired - Fee Related
-
2003
- 2003-12-12 US US10/735,497 patent/US7070762B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,199 patent/US7070761B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,198 patent/US7008615B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,496 patent/US7005121B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/734,902 patent/US7029658B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,537 patent/US7078017B2/en not_active Expired - Lifetime
- 2003-12-30 US US10/750,303 patent/US7078020B2/en not_active Expired - Lifetime
- 2003-12-30 US US10/749,539 patent/US7078018B2/en not_active Expired - Lifetime
- 2003-12-30 US US10/749,536 patent/US7094392B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,535 patent/US7115250B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,783 patent/US7078019B2/en not_active Expired - Fee Related
-
2004
- 2004-01-27 US US10/766,149 patent/US7087216B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,647 patent/US7070764B2/en not_active Expired - Fee Related
- 2004-01-27 US US10/766,634 patent/US7070763B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,574 patent/US7045118B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,566 patent/US7060254B2/en not_active Expired - Fee Related
- 2004-01-27 US US10/766,279 patent/US7087217B2/en not_active Expired - Fee Related
- 2004-01-28 US US10/767,115 patent/US7052679B2/en not_active Expired - Lifetime
- 2004-01-29 US US10/768,205 patent/US7070765B2/en not_active Expired - Lifetime
- 2004-01-29 US US10/768,220 patent/US7063830B2/en not_active Expired - Fee Related
- 2004-01-29 US US10/769,197 patent/US7063831B2/en not_active Expired - Fee Related
- 2004-01-29 US US10/768,281 patent/US7169378B2/en not_active Expired - Lifetime
- 2004-01-29 US US10/768,293 patent/US7067114B2/en not_active Expired - Fee Related
- 2004-01-30 US US10/769,046 patent/US7070766B2/en not_active Expired - Fee Related
- 2004-01-30 US US10/769,051 patent/US7033575B2/en not_active Expired - Fee Related
- 2004-02-09 US US10/775,583 patent/US7018620B2/en not_active Expired - Fee Related
- 2004-02-09 US US10/775,586 patent/US7048909B2/en not_active Expired - Fee Related
- 2004-03-03 US US10/791,915 patent/US7005122B2/en not_active Expired - Fee Related
- 2004-03-03 US US10/792,239 patent/US7014840B2/en not_active Expired - Fee Related
- 2004-03-31 US US10/814,998 patent/US7108847B2/en not_active Expired - Fee Related
- 2004-03-31 US US10/813,721 patent/US7022312B2/en not_active Expired - Lifetime
- 2004-03-31 US US10/814,690 patent/US7014841B2/en not_active Expired - Lifetime
- 2004-03-31 US US10/813,722 patent/US7063832B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/816,407 patent/US7011820B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/816,567 patent/US7052680B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/816,492 patent/US7008616B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/815,527 patent/US6994843B2/en not_active Expired - Fee Related
-
2006
- 2006-03-07 US US11/370,628 patent/US7442368B2/en not_active Expired - Fee Related
- 2006-04-04 US US11/398,383 patent/US7449172B2/en not_active Expired - Lifetime
- 2006-05-24 US US11/439,475 patent/US7465435B2/en not_active Expired - Fee Related
- 2006-05-30 US US11/442,917 patent/US7465436B2/en not_active Expired - Fee Related
- 2006-06-13 US US11/451,853 patent/US7485285B2/en not_active Expired - Fee Related
- 2006-06-16 US US11/454,573 patent/US7465437B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,509 patent/US7507398B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,892 patent/US7449174B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,361 patent/US7524484B2/en not_active Expired - Fee Related
- 2006-07-05 US US11/481,279 patent/US7449175B2/en not_active Expired - Fee Related
- 2006-07-18 US US11/488,943 patent/US20060257329A1/en not_active Abandoned
- 2006-07-18 US US11/488,932 patent/US7601337B2/en not_active Expired - Lifetime
- 2006-08-07 US US11/500,735 patent/US7445768B2/en not_active Expired - Fee Related
- 2006-08-07 US US11/501,246 patent/US7510702B2/en not_active Expired - Fee Related
- 2006-08-22 US US11/507,986 patent/US7491047B2/en not_active Expired - Fee Related
- 2006-09-19 US US11/523,685 patent/US7507397B2/en not_active Expired - Fee Related
-
2007
- 2007-01-09 US US11/621,397 patent/US7468179B2/en not_active Expired - Fee Related
-
2008
- 2008-03-27 US US12/057,330 patent/US7988952B2/en not_active Expired - Fee Related
-
2009
- 2009-03-27 US US12/413,339 patent/US8173107B2/en not_active Expired - Lifetime
-
2010
- 2010-07-23 JP JP2010165688A patent/JP5629151B2/ja not_active Expired - Lifetime
-
2013
- 2013-08-19 FR FR13C0051C patent/FR13C0051I1/fr active Active
- 2013-08-19 BE BE2013C054C patent/BE2013C054I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE462421T1 (de) | Kondensationsaerosol enthaltend loxapine oder prochlorperazine zur inhalation | |
WO2002094244A3 (en) | Delivery of benzodiazepines through an inhalation route | |
WO2002094218A3 (en) | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route | |
AU2002366203A1 (en) | Medicament dispensing system | |
AU5900701A (en) | Novel composition | |
HK1151987A1 (en) | Pharmaceutical compositions for the treatment of asthma | |
WO2003045484A3 (en) | Open-celled substrates for drug delivery | |
WO2002094216A3 (en) | Delivery of stimulants through an inhalation route | |
MXPA04007294A (es) | Composicion para inhalacion. | |
WO2002094246A3 (en) | Delivery of nonsteroidal antiinflammatory drugs through an inhalation route | |
WO2003094694A3 (en) | Hand held device for inhalation therapy and method of use thereof | |
GT200000101A (es) | Sistemas y metodos de formulaciones farmaceuticas para aerosoles. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |